# SIGNABLOK, INC.: New TREM-1 therapy for inflammatory bowel disease

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | SIGNABLOK, INC. |
| Location | WORCESTER, MA |
| Project | New TREM-1 therapy for inflammatory bowel disease |
| Project number | 1R43DK148026-01 |
| Mechanism | R43 |
| Institute | National Institute of Diabetes and Digestive and Kidney Diseases |
| Award | $353,264 |
| Awarded | 2026-09-04 |
| Project period | 2026-09-04 to 2027-08-31 |
| UEI | JM5UN38YM1H7 |

## Why this score
- Award of $353,264.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11387185). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.